Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells
ConclusionOur results suggest that CSCs in the ER+ cells escape the effect of DOX treatment by the elevation of p53 expression.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Egypt Health | Genetics | Stem Cell Therapy | Stem Cells | Study